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Abstract
Sedoheptulose-7-phosphate isomerase, GmhA, is the first enzyme in the biosynthesis
of nucleotide-activated-glycero-manno-heptoses and an attractive, yet underexploited,
target for development of broad-spectrum antibiotics. We demonstrated that GmhA
homologs in Neisseria gonorrhoeae and N. meningitidis (hereafter called GmhAGC and
GmhANM, respectively) were interchangeable proteins essential for lipooligosaccharide (LOS) synthesis, and their depletion had adverse effects on neisserial viability. In
contrast, the Escherichia coli ortholog failed to complement GmhAGC depletion.
Furthermore, we showed that GmhAGC is a cytoplasmic enzyme with induced expression at mid-logarithmic phase, upon iron deprivation and anaerobiosis, and conserved
in contemporary gonococcal clinical isolates including the 2016 WHO reference
strains. The untagged GmhAGC crystallized as a tetramer in the closed conformation
with four zinc ions in the active site, supporting that this is most likely the catalytically
active conformation of the enzyme. Finally, site-directed mutagenesis studies showed
that the active site residues E65 and H183 were important for LOS synthesis but not
for GmhAGC function in bacterial viability. Our studies bring insights into the importance and mechanism of action of GmhA and may ultimately facilitate targeting the
enzyme with small molecule inhibitors.
KEYWORDS

crystal structure, drug target, Neisseria gonorrhoeae, sedoheptulose-7-phosphate isomerase
GmhA

1 | INTRODUCTION

including infections caused by drug-resistant Neisseria gonorrhoeae
(Centers for Disease Control and Prevention, 2013a, 2013b; World

The World Health Organization (WHO) and the Centers for Disease

Health Organization, 2012, 2015). Gonorrhea is highly prevalent

Control and Prevention (CDC) emphasized an urgent need for the

throughout the world, and if untreated or inadequately treated, often

development of antimicrobials with novel modes of action against

leads to serious repercussions on reproductive health including ecto-

antibiotic-resistant threats with severe consequences for public health,

pic pregnancy, pelvic inflammatory disease, and infertility (Centers For
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Disease Control And Prevention, 2013b, Low, Unemo, Skov Jensen,

α, β, and χ (Gibson et al., 1989; John, Griffiss, Apicella, Mandrell,

Breuer, & Stephenson, 2014; World Health Organization, 2011). In

& Gibson, 1991; Yamasaki, Bacon, Nasholds, Schneider, & Griffiss,

the absence of a protective gonorrhea vaccine, antibiotics remain the

1991). The individual chains can be decorated with structures that

sole therapeutic intervention. However, the well-documented ability

mimic human carbohydrate epitopes (α chain linked to Hep I; Apicella

of gonococci to acquire antibiotic resistance continues to threaten

& Mandrell, 1989); a single glucose, lactose, or glucose with additional

available treatment options (Unemo, 2015; Unemo & Shafer, 2014).

sugars (β chain extending from Hep II; Gibson et al., 1989; Yamasaki

To meet the needs raised by WHO and CDC, our laboratory focuses on

et al., 1994); and GlcNac, GlcNac acetate, or occasionally galactose

identification and validation of new molecular targets for the develop-

(χ chain; Mcleod Griffiss, Brandt, Saunders, & Zollinger, 2000). In ad-

ment of gonorrhea treatments (Bonventre, Zielke, Korotkov, & Sikora,

dition, phosphate or phosphoethanolamine groups may be attached

2016; Zielke, Wierzbicki, Baarda, & Sikora, 2015; Zielke, Wierzbicki,

to the heptose residues (Preston, Mandrell, Gibson, & Apicella, 1996;

Weber, Gafken, & Sikora, 2014; Zielke et al., 2016).

Raetz & Whitfield, 2002). The phosphoric residues participate in the

Targeting the first enzymes in the nucleotide-activated-glycero-

ionic interactions between LPS/LOS and outer membrane proteins, as

manno-heptose pathways is a relatively unexplored field, although

well as divalent cations, providing a barrier against entry of detergents,

it appears to be an alternative approach to the discovery of broad-

antibiotics, and hydrophobic compounds (Preston et al., 1996; Raetz

spectrum antibacterial drugs (Bauer, Stevens, & Hansen, 1998; Darby,

& Whitfield, 2002). The N. gonorrhoeae heptose-monophosphate was

Ananth, Tan, & Hinnebusch, 2005; Tamaki, Sato, & Matsuhashi, 1971;

recently linked with the clinical and epidemiological synergy of gon-

Valvano, Messner, & Kosma, 2002). Nucleotide-activated-glycero-

orrhea and HIV (Malott et al., 2013). At the molecular level, this in-

manno-heptoses, while absent in eukaryotic cells, are widely present in

terplay involves the unique ability of gonococci to efficiently liberate

bacteria and are crucial components of the lipopolysaccharides (LPS),

phosphorylated L,D-heptose into the extracellular milieu, which elicits

lipooligosaccharides (LOS), capsules, O-antigens, and glycan moieties

an immune response and induces HIV-1 expression and viral produc-

of bacterial cell surface (S-layer) glycoproteins (Valvano et al., 2002).

tion in cluster of differentiation 4-positive (CD4+) T cells (Malott et al.,

In particular, one such potential drug target of significant interest is

2013).

sedoheptulose-7-phosphate isomerase, GmhA, annotated previously

Mutations in genes encoding GmhA in different bacterial species

as TfrA (Havekes, Lugtenberg, & Hoekstra, 1976) and LpcA (Brooke

examined to date resulted in pleiotropic effects including produc-

& Valvano, 1996a). GmhA is conserved in many Gram-negative and

tion of truncated LPS/LOS composed of lipid A and KDO residues,

some Gram-positive bacteria and is responsible for catalyzing isom-

increased susceptibility to antibiotics and detergents, impaired bio-

erization of the D-sedoheptulose 7-phosphate into D-glycero-α,β-D-

film formation, and attenuated virulence (Aballay, Drenkard, Hilbun,

manno-heptose-7-phosphate (Eidels & Osborn, 1974), which is the

& Ausubel, 2003; Bauer et al., 1998; Brooke & Valvano, 1996b; Darby

first and common step for parallel biosynthetic pathways leading to

et al., 2005). In addition, lack of HldA, which acts immediately down-

generation of GDP-D-glycero-α-D-manno-heptose (D,D-heptose)

stream from GmhA in the L,D-heptose biosynthetic pathway, ren-

and ADP-L-glycero-β-D-manno-heptose [L,D-heptose; reviewed in

dered gonococci unable to induce HIV-1 expression (Malott et al.,

Ref: (Valvano et al., 2002)]. D,D-heptose is required for glycosyla-

2013). Therefore, we propose GmhA in N. gonorrhoeae, GmhAGC, as

tion of flagella and capsular polysaccharides, and for the assembly

a molecular target for the development of new antigonococcal drugs.

of disaccharide repeating units (D,D-heptose linked to L-rhamnose)

Herein, we performed characterization of GmhAGC at the molecular,

composing the S-layer glycan in the Gram-positive Eubacterium,

functional, and structural levels to facilitate the future targeting of this

Aneurinibacillus thermoaerophilus DSM 10155 (Eidels & Osborn, 1974;

enzyme with small molecule inhibitors.

Kosma, Wugeditsch, Christian, Zayni, & Messner, 1995; Wugeditsch
et al., 1999). L,D-heptose is used for glycosylation of capsular polysaccharides (Valvano et al., 2002) and as a primary building block of LPS/
LOS core oligosaccharide (Brooke & Valvano, 1996a; Eidels & Osborn,
1971). In addition, a large family of bacterial autotransporter heptos-

2 | EXPERIMENTAL PROCEDURES
2.1 | Bacterial strains and growth conditions

yltransferases (BAHTs) utilizes L,D-heptose as a sugar donor to modify

Strains of bacteria used in this study are listed in Table 1. Neisseria

serine residues on their substrate autotransporters, which has a signif-

gonorrhoeae and N. meningitidis were cultured either on gonococcal

icant impact on the virulence of Gram-negative pathogens (Lu, Li, &

base solid medium (GCB, Difco), or in gonococcal base liquid (GCBL)

Shao, 2015). The L,D-heptose is synthesized in sequential reactions

medium supplemented with Kellogg’s supplement I and II in ratios

catalyzed in order by GmhA-HldE(HldA)-GmhB-HldE(HldC)-HldD

1:100 and 1:1,000, respectively (Spence, Wright, & Clark, 2008).

[reviewed in Refs: (Raetz & Whitfield, 2002; Valvano et al., 2002)].

GCBL was additionally supplemented with sodium bicarbonate at a

Usually one or more L,D-heptose molecules and two 2-keto-3-deoxy-

final concentration of 0.042%. In vitro host-relevant growth condi-

D-manno-oct-2-ulosonic acid (KDO) residues form the inner portion

tions (iron deprivation, presence of normal human serum, anoxia)

(lipid A proximal) of the LPS/LOS core oligosaccharide, which is typi-

were procured as described previously (Zielke et al., 2016). Neisseria

cally more conserved than the structurally diverse outer core (Raetz &

were cultured on solid media for 18–22 hr at 37°C in the presence of

Whitfield, 2002). Similarly, gonococcal LOS contain two basal heptose

5% atmospheric CO2. For N. gonorrhoeae, piliated or nonpiliated vari-

molecules, designated Hep I and Hep II, forming elongation centers

ants were passaged onto GCB and incubated for additional 18–22 hr.

|
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TABLE 1

Bacterial strains used in this study

Bacterial strains

3 of 16

MC58, and E. coli BL21(DE3) was isolated with the Wizard Genomic
Reference

N. gonorrhoeae
FA1090

(Connell et al.,
1988)

MS11

(Meyer, Mlawer, &
So, 1982)

1291

(Apicella, Breen, &
Gagliardi, 1978)

F62

(Sparling, 1966)

FA1090 ∆gmhAGC/Plac:: gmhAGC

This study

FA1090 ∆gmhAGC/Plac:: gmhAGC E65A

This study

FA1090 ∆gmhAGC/Plac:: gmhAGC H183A

This study

FA1090 ∆gmhAGC/Plac:: gmhANM

This study

Baltimore collection 1991–1994:
LGB1, LG14, LG2, LGB26, LG20

(Garvin et al., 2008;
Zielke et al., 2014)

Clinical isolates from Public Health–Seattle
& King County Sexually Transmitted
Disease Clinic:
UW01, UW02, UW03, UW04, UW05,
UW06, UW07, UW08, UW09, UW10,
UW11, UW12, UW13

(Zielke et al., 2016)

2016 WHO reference strains:F, G, K, L, M,
N, O, P, W, X, Y, Z, U, V

(Unemo et al., 2016)

DNA Purification Kit (Promega). PCR products and plasmid DNA were
purified using QIAprep Spin Miniprep Kit (QIAGEN). PCR reactions
were performed using chromosomal or plasmid DNA as template, appropriate oligonucleotides, and Q5® High-Fidelity DNA Polymerase
(NEB). E. coli MC1061 was used as the host during the molecular
cloning and site-directed mutagenesis procedures. All created constructs and suppressor mutations in ∆gmhAGC/Plac::gmhAGC were verified by Sanger Sequencing at the Center for Genomic Research and
Biocomputing at Oregon State University. Transformation of N. gonorrhoeae and N. meningitidis was performed as described previously
(Alexander, Richardson, & Stojiljkovic, 2004; Zielke et al., 2014).
The recombinant GmhAGC (rGmhAGC) containing N-terminal-6 ×
His-tag followed by the tobacco etch virus (TEV) protease recognition
site was obtained by amplifying the DNA region of the ngo1986 lacking
stop codon with primers rNGO1986-F and rNGO1986-R and cloning
the obtained PCR product (615 bp) into NcoI/HindIII sites of pRSF-NT
(Table S1).
The conditional GmhAGC mutant, FA1090 ∆gmhAGC/Plac::gmhAGC,
was constructed using a strategy as described by (Zielke et al., 2016)
by placing an additional copy of ngo1986 under the control of the
isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible promoter,
Plac, within an intergenic region located between lctP and aspC in
the FA1090 chromosome (Mehr, Long, Serkin, & Seifert, 2000) and a

N. meningitidis

subsequent in-frame replacement of the ngo1986 in its native chro-

MC58

(McGuinness et al.,
1991)

mosomal locus with the nonpolar kanamycin resistance cassette.

MC58 ∆gmhANM/Plac:: gmhANM

This study

MC58 ∆gmhANM/Plac:: gmhAGC

This study

(RBS) was amplified with primers NGO1986-RBS-F and NGO1986-

E. coli

Specifically, the ngo1986 containing its native ribosomal binding site
RBS-R. The resulting 628 bp PCR product was digested with FseI and
inserted into ScaI/FseI-treated pGCC4, yielding pGCC4-GmhAGC.

MC1061

(Casadaban &
Cohen, 1980)

After transformation of FA1090 with pGCC4-GmhAGC, gonococci

BL21(DE3)

(Studier & Moffatt,
1986)

PCR with primers pGCC4-Ver-F and pGCC4-Ver-R.

were selected on GCB with 0.5 μg/ml erythromycin and verified by
The constructs for deletion of gmhAGC were obtained by amplification of the 552 bp upstream DNA region and 571 bp downstream

Colonies with piliated morphology were used for DNA transforma-

from ngo1986 with primers NGO1986-UP-F/NGO1986-UP-R and

tion, while nonpiliated variants were used in all other experiments.

NGO1986-Down-F/NGO1986-Down-R, respectively. The upstream

Escherichia coli strains were grown either on Luria–Bertani agar (LBA,

fragment was digested with EcoRI/KpnI and cloned into similarly

Difco) or cultured in Luria–Bertani broth (LB, Difco) at 37°C.

cleaved pUC18K, yielding pUC18K-GmhAGC-Up. Next, the down-

Antibiotics were used on selected bacteria in the following concentrations: for N. gonorrhoeae: kanamycin 40 μg/ml, erythromycin
0.5 μg/ml; for N. meningitidis: kanamycin 80 μg/ml, erythromycin 2 μg/
ml; for E. coli: kanamycin 50 μg/ml, erythromycin 250 μg/ml.

stream fragment was inserted into the BamHI/HindIII-cleaved
pUC18K-GmhAGC-Up. The resulting pUC18K-GmhAGC was linearized with HindIII and used to transform FA1090 carrying the second copy of GmhA on the chromosome, FA1090Plac::gmhAGC. Clones
were selected on a solid medium supplemented with kanamycin and

2.2 | Genetic manipulations, site-directed
mutagenesis, and transcomplementation
Plasmids and primers used in this study are listed in Table S1.
Oligonucleotides were designed based on the genomic sequence
of N. gonorrhoeae FA1090 (NC_002946), N. meningitidis MC58

0.1 mmol/L IPTG, and verified by PCR with NGO1986-Ver-F and
NGO1986-Ver-R primers. Subsequently, selected gonococci were further verified by immunoblotting analyses using anti-GmhAGC antisera.
To generate GmhAGCE65A and GmhAGCH183A, the template
for site-directed mutagenesis (pUC18-GmhAGC) was constructed by
amplifying ngo1986 with its native RBS using primers NGO1986-

(NC_003112), and E. coli BL21(DE3) (NC_012892) using SnapGene

RBS-F and NGO1986-RBS-R and cloning into SmaI-cleaved pUC18.

software version 2.8 (GSL Biotech LLC) and synthesized by IDT

Site-directed mutagenesis was performed using the template; primer

Technologies. Genomic DNA of gonococcal strains, N. meningitidis

pairs E65A-F/E65A-R or H183A-F/H183A-R, respectively, and Q5

4 of 16
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Site-Directed Mutagenesis Kit (NEB), according to the manufacturer’s

10 min. Samples were allowed to cool down to room temperature and

manual. Subsequently, the mutated variants of GmhAGC were ampli-

proteins were digested by addition of 25 μg proteinase K in 10 μl of

fied with NGO1986-RBS-F and NGO1986-RBS-R, cleaved with FseI,

lysis buffer and incubated for 1 hr at 60°C. Isolated LOS was resolved

cloned into ScaI/FseI-digested pGCC4, introduced into the FA1090

on 16.5% Mini-PROTEAN® Tris-Tricine Gel (Bio-Rad) and visualized

chromosome, and the native ngo1986 was deleted as described above.

by a silver staining procedure (Tsai & Frasch, 1982).

For transcomplementation studies, GmhA homologs from N. meningitidis MC58 (nmb2090) and E. coli BL21(DE3) (ECBD_3400) were
amplified with primer pairs NGO1986-RBS-F/NGO1986-RBS-R and
ECBD3400-RBS-F, respectively. The resulting PCR products were

2.6 | Fitness assessment
Colonies of different neisserial strains, as indicated in the text, were

digested with FseI and introduced into ScaI/FseI-treated pGCC4.

collected from GCB and reconstituted in GCBL to OD600 of 0.1.

Introduction into the FA1090 chromosome and deletion of GmhA

Bacterial cultures were incubated in the absence of IPTG for 3 hr at

were performed as outlined above.

37°C with aeration and subsequently back-diluted to OD600 of 0.2,

The cytoplasmic marker control for subfractionation experi-

serially diluted, and plated on GCB with or without IPTG for CFUs

ments, the zwf gene (ngo0715) encoding glucose-6-phosphate-1-

scoring. Experiments were repeated in three biological replicates and

dehydrogenase was amplified using primers RAZ548 and RAZ549.

mean values with corresponding SEM are presented.

The PCR product was cleaved with NcoI and HindIII and cloned into
similarly digested pRSF-NT to obtain plasmid pRSF-NT-Zwf.

2.3 | Proteome subfractionation procedures
Colonies of N. gonorrhoeae FA1090 were collected from GCB, sus-

2.7 | Purification of the rGmhAGC and rZwf and
production of polyclonal rabbit antibodies
E. coli BL21(DE3) strain carrying either pRSF-NT-GmhAGC or pRSF-
NT-Zwf was used as heterologous host for overproduction and pu-

pended in 500 ml of GCBL to OD600 of 0.1, and cultured with aera-

rification of rGmhAGC and recombinant Zwf (rZwf), respectively.

tion at 37°C until OD600 of ~0.8. Bacterial cells were separated from

Overnight cultures were back-diluted in 2.0 L of LB supplemented

the suspension by centrifugation (10 min, 6,000g, 4°C). The crude cell

with kanamycin and incubated with aeration at 37°C until the opti-

envelopes were purified using a sodium carbonate extraction proce-

cal density (OD600) reached ~0.5. Overproduction of rGmhAGC and

dure while naturally released membrane vesicles (MVs) and soluble

rZwf was induced with 0.1 and 1 mmol/L IPTG, respectively, and

proteins (SS) were fractionated from culture supernatants by ultracen-

cultures were incubated for additional 3 hr at 37°C. Cells were har-

trifugation as described previously (Zielke et al., 2016).

vested by centrifugation (6,000g, 10 min, 4°C). Pelleted bacteria carrying pRSF-NT-GmhAGC were suspended in lysis buffer (20 mmol/L

2.4 | GmhAGC depletion studies

Tris-HCl pH 7.0, 1 mol/L NaCl, 10 mmol/L imidazole, 5% glycerol)
supplemented with a Pierce Protease Inhibitor Mini Tablet (Thermo

Colonies of FA1090 ∆gmhAGC/Plac:: gmhAGC were collected with a

Scientific) and lysed by passaging six times through a French pres-

cotton swab from GCB supplemented with 10 μmol/L IPTG and sus-

sure cell at 12,000 psi. Cell debris and unbroken cells were separated

pended in GCBL to OD600 of 0.1. After two washes in prewarmed

from soluble protein fraction by centrifugation at 16,000g for 30 min

GCBL, bacterial suspension was split and incubated with shaking

at 4°C. The supernatant was passed through 0.22 μm membrane filter

(220 rpm) with or without IPTG for 3 hr at 37°C. Cultures were back-

(VWR International) and applied onto Bio-Scale MiniProfinity IMAC

diluted to OD600 of 0.1 in fresh GCBL, as described above, and cul-

cartridges (Bio-Rad) on the NGC Scout Chromatography system (Bio-

tured for additional 6 hr. At specific time points indicated in the text,

Rad). Loosely bound proteins were removed with 10 column volumes

OD600 measurements were taken, samples for western blotting and

of wash buffer (20 mmol/L Tris pH 8.0, 500 mmol/L NaCl, 40 mmol/L

LOS isolation were withdrawn, and cultures were serially diluted fol-

imidazole) and elutions were conducted with a 40–250 mmol/L

lowed by plating on GCB for enumeration of colony-forming units

imidazole gradient. Fractions containing rGmhAGC were combined

(CFUs). Experiments were performed on three separate occasions and

and a PD-10 column (GE Healthcare) was used to exchange the

mean values and SEM are presented.

buffer to 20 mmol/L HEPES pH 7.5, 100 mmol/L NaCl, 5% glycerol.
Subsequently, the N-terminal-6 × His-tag of the rGmhAGC was re-

2.5 | Isolation of LOS and silver staining

moved by TEV protease. Cleavage reaction was prepared by mixing
rGmhAGC with TEV in 20:1 (w:w ratio) in 500 μl of cleavage buffer

LOS was isolated from N. gonorrhoeae and N. meningitidis based on

(0.5 mol/L Tris-HCl pH 8.0, 5 mmol/L EDTA), 10 μl of 0.5 mol/L DTT,

the method described previously (Hitchcock & Brown, 1983). Bacteria

and 500 μl of Ni-NTA agarose (Qiagen) equilibrated with cleavage

were either collected from GCB or GCBL, as specified in the text, sus-

buffer. Following overnight incubation at room temperature, cleav-

pended in 1.5 ml of GCBL to OD600 of 0.2 and spun down for 1.5 min

age mixture was loaded onto a 5 ml polypropylene column (Thermo

at 15,000g. Pelleted cells were lysed by addition of 50 μl of lysis buffer

Scientific) and supernatant containing 6 × His-tag-free rGmhAGC was

(2% SDS, 4% β-mercaptoethanol, 10% glycerol, 1mol/L Tris-HCl

collected. To remove residual TEV protease that coeluted with rGm-

pH 6.8, and 0.01% bromophenol blue) and incubation at 100°C for

hAGC, the mixture was incubated again with 500 μl of Ni-NTA agarose

|
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(Qiagen) equilibrated with cleavage buffer for 1 hr with rotation at

and scaled using XDS and XSCALE (Kabsch, 2010a). The structure was

4°C, and rGmhAGC was eluted. The purified rGmhAGC was applied to a

solved by molecular replacement using Phaser (McCoy et al., 2007)

PD-10 column (GE Healthcare) for a buffer exchange into 20 mmol/L

and structure of Pseudomonas aeruginosa GmhA (PDB 3BJZ) as a

HEPES pH 7.5, 100 mmol/L NaCl, and 5% glycerol.

search model (Taylor et al., 2008). The electron density modification

Purification of rZwf was accomplished using the same procedures

was performed using Parrot (Cowtan, 2010) followed by automated

as described above with the following modifications. E. coli cells were

model rebuilding using Buccaneer (Cowtan, 2006). The model was

resuspended in lysis buffer (20 mmol/L Tris-HCl pH 8.0, 10 mmol/L

completed by manual rebuilding in Coot (Emsley, Lohkamp, Scott, &

imidazole, 450 mmol/L NaCl). Cells were lysed using French Press and

Cowtan, 2010) and was refined using REFMAC5 (Murshudov et al.,

rZwf was purified using 5 ml Bio-Scale Mini Nuvia IMAC Ni-Charged

2011). The structure was validated using Coot and the MolProbity

column (Bio-Rad) connected to a NGC Chromatography System (Bio-

server (Chen et al., 2010). The structural figures were generated

Rad). Bound peptides were eluted using elution buffer (20 mmol/L

using PyMol (The PyMOL Molecular Graphics System, Version 1.8

Tris-HCl pH 8.0, 250 mmol/L imidazole, 450 mmol/L NaCl). Fractions

Schrödinger, LLC.).

containing proteins were pooled, EDTA and DTT were added to final
concentrations of 0.5 mmol/L and 1 mmol/L, respectively, and the
His-tag was removed by overnight incubation with TEV protease (ratio

2.10 | SDS-PAGE and immunoblotting

1:100 w/w). After cleavage, the proteins were separated using Hi Load

Whole cell lysates of Neisseria strains indicated in the text were ei-

16/600 Superdex 75 pg column (GE Healthcare) and buffer contain-

ther collected from solid media after 22 hr of aerobic or 48 hr of an-

ing 20 mmol/L Tris pH 8, 150 mmol/L NaCl connected to the NGC

aerobic growth, or harvested from liquid media following procedures

Chromatography System. Fractions containing Zwf were pooled to-

described (Zielke et al., 2014, 2016). E. coli cells were collected from

gether and concentrated using 10 kDa Vivaspin 20 concentrators (GE

LB agar plates after overnight incubation. Samples were normalized

Healthcare). Glycerol was added to a final concentration of 10% and

based on OD600 values or based on total protein concentration, and

the protein was aliquoted and stored at −80°C.
The polyclonal rabbit anti-GmhAGC and anti-Zwf antibodies were
generated using 6 × His-tag-free rGmhAGC and rZwf, respectively.

SDS-PAGE, staining with Coomassie brilliant blue G-250, and immunoblotting analyses were performed exactly as described previously
(Zielke et al., 2014, 2016).

Standard 13-week antibody production protocols were applied, utilizing four New Zealand White rabbits, animal handling was performed
according to the Animal Protocol #1 approved by IACUC, in a certified

2.11 | Statistical analysis

animal facility (USDA 93-R-283) and the NIH Animal Welfare Assurance

GraphPad Prism’s build-in t-test was used for determination of statis-

Program (#A4182-01) at the Pacific Immunology Corporation. Anti-

tically significant differences between obtained experimental results.

GmhAGC and anti-Zwf antisera were used at 1:10,000.

A confidence level of 95% was used for all analyses.

2.8 | Size exclusion chromatography

2.12 | Accession numbers

The NGC Scout Chromatography system (Bio-Rad) employing a

The coordinates and structure factors were deposited to the Protein

HiLoad 16/600 Superdex 75 pg column (GE Healthcare Life Sciences)

Data Bank with accession code 5I01.

was used to separate purified rGmhAGC based on the molecular
size. Buffer for the chromatography (20 mmol/L Tris-HCl pH 8.0,
500 mmol/L NaCl) was applied at 1 ml/min flow rate. Gel Filtration
Standard (Bio-Rad) was used to determine the size of the separated
proteins.

2.9 | Crystallization and structure determination of
N. gonorrhoeae GmhAGC

3 | RESULTS
3.1 | Chromosomal location and purification of
GmhAGC
Genes encoding the enzymes of L,D-heptose biosynthesis pathway
are scattered throughout the chromosome in the majority of bacteria
including N. gonorrhoeae (Valvano et al., 2002). The GmhA homolog

The screening for initial crystallization conditions was performed

in N. gonorrhoeae strain FA1090 is encoded by ngo1986, which is lo-

using JCSG Core Suites I-IV (Qiagen) (Newman et al., 2005). The

cated between ngo1985, coding for an outer membrane lipoprotein

optimized crystals were grown using 0.1 mol/L Tris-HCl pH 8.5,

(Zielke et al., 2014) and ngo1987 encoding a putative endonuclease

0.2 mol/L magnesium chloride, 30% PEG4000. Crystals were trans-

(YraN). Comparison of the gmhA location using BioCyc Pathway/

ferred to a cryoprotectant solution supplemented with 20% glyc-

Genome Database Collection (http://biocyc.org/) showed that this

erol and flash-frozen in liquid nitrogen. The diffraction data were

genetic arrangement is conserved among the various deposited

collected from a single crystal at the beamline 22-ID, Southeast

Neisseria species and isolates (n = 70) with only a few exceptions, in-

Regional Collaborative Access Team (SER-CAT) at the Advanced

cluding N. bacilliformis ATCC BAA-1200, N. sp. oral taxon 020 F0370,

Photon Source, Argonne National Laboratory. Data were integrated

N. shayeganii 871, and N. subflava NJ9703.
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GmhAGC consists of 197 amino acids with residues 37–197 comprising a sugar isomerase domain (SIS) (Bateman, 1999) that is shared

Bacterial growth
(Log10 CFU/ml)

Bacterial growth (OD600)

(d)

IPTG (–)
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7

0

1

2

3

*

*

4

5

6

Time (hr)
the phosphate group of sedoheptulose 7-phosphate or D-glycero-
D-manno-heptose 7-phosphate (Harmer, 2010; Valvano et al., 2002).

between all ketose/aldose isomerases (Golinelli-Pimpaneau, Le Goffic,

To characterize GmhAGC, we first purified recombinant protein

& Badet, 1989). At the amino acid level, GmhAGC shows 43–57% iden-

with an N-terminal 6 × His-tag followed by the tobacco etch virus

tity with crystallized orthologous proteins (Table 3) and contains the

(TEV) protease cleavage site and prepared untagged protein. Size ex-

key conserved residues observed in all GmhA homologs, including

clusion chromatography indicated that the native GmhAGC forms te-

three serine residues and a threonine that presumably interact with

trameric structures in the solution (Fig. S1A). The denatured protein
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F I G U R E 1 GmhAGC is pivotal for N. gonorrhoeae growth and lipooligosaccharide (LOS) synthesis. (a) The N. gonorrhoeae FA1090 gmhAGC
conditional knockout strain, ∆gmhAGC/Plac::gmhAGC, was streaked out from frozen glycerol stock on solid media supplemented with 20 μmol/L
isopropyl β-D-1-thiogalactopyranoside (IPTG). After 18 hr incubation at 37°C in the presence of 5% atmospheric CO2, the colonies were
passaged onto plates either with (+) or without IPTG (−). (b) Whole cell lysates of FA1090 wild-type and isogenic ∆gmhAGC/Plac::gmhAGC
harvested from plates with (+) or without 20 μmol/L IPTG (−) were either probed with polyclonal rabbit antisera or subjected to LOS extraction
using proteinase K followed by silver staining. (c–e) The FA1090 ∆gmhAGC/Plac::gmhAGC cells were collected from solid media supplemented with
20 μmol/L IPTG, suspended to OD600 of 0.1, washed twice, divided, and cultured either in the presence or absence of IPTG for 3 hr. At time
point designated as 0 hr, corresponding cultures were back-diluted to the same density (OD600 of 0.1) into fresh media with or without IPTG
and incubated for additional 6 hr. Samples of bacterial cultures were collected every hour for GmhAGC and Ng-MIP immunoblotting analysis,
LOS, and whole cell protein profiles (c), monitoring of bacterial proliferation by measurement of density of the cultures at OD600, (d) and spotting
serially diluted bacteria on solid media with IPTG for CFU scoring (e). Whole cell lysates were matched by the same OD600 units. As loading
control, samples separated by SDS-PAGE were either probed with anti-Ng-MIP antibodies or stained with Coomassie brilliant blue
G-250. The migration of molecular mass marker (kDa) is indicated on the left. All experiments were performed in three biological replicates.
Means and SEM are presented on graphs; *p < .05

migrated on SDS-PAGE according to the predicted molecular mass of

(CFUs; Figure 1e). Immunoblotting with anti-GmhAGC antisera showed

21.093 kDa (Fig. S1B). Untagged GmhAGC was subsequently used in

that in the absence of IPTG, GmhAGC levels were slightly decreased

crystallization and to obtain polyclonal rabbit antisera.

at 0 hr and complete GmhAGC depletion was achieved three hours
later (Figure 1c). Also, it was noted that despite the presence of inducer, GmhAGC had a peculiar expression pattern; decreased amounts

3.2 | N. gonorrhoeae deprived of GmhAGC displays
defect in LOS synthesis and growth cessation

of protein in comparison with these observed at 0 hr were detected

The genetic inactivation of gmhA in E. coli, Haemophilus influenzae,

Furthermore, increased GmhAGC levels were found in late-log phase

H. ducreyi, Salmonella enterica, and Yersinia pestis resulted in altered

(4, 5 hr) followed by a decline in stationary phase (6 hr; Figure 1c–e).

outer membrane permeability and decreased virulence in animal in-

In contrast, no major differences were noticed in the overall protein

at 1 hr and in early-log phase (corresponding to 2–3 hr data points).

fection models, however, the mutants did not display drastic growth

profiles and the level of Ng-MIP (Figure 1c), which is ubiquitously ex-

defects in vitro (Aballay et al., 2003; Bauer et al., 1998; Brooke &

pressed throughout phases of gonococci growth (Zielke et al., 2016).

Valvano, 1996b; Darby et al., 2005). Therefore, we were surprised

As expected based on data presented in Figure 1b, the wild-type

by the failure of our numerous attempts to generate a clean deletion

LOS species diminished over time and were barely detectable upon

of ngo1986 in N. gonorrhoeae FA1090. As an alternative strategy, an

GmhAGC diminution (Figure 1c). Finally, analysis of culture density and

additional copy of gmhAGC was placed under the control of the IPTG-

number of viable gonococci showed that in media lacking IPTG, bacte-

inducible Plac promoter and introduced into the chromosome of wild-

rial growth was greatly reduced concomitant to depletion of GmhAGC

type FA1090, followed by an allelic replacement of ngo1986 with the

(Figure 1c–e), whereas in the presence of IPTG, the generation time of

kanamycin resistance cassette. The obtained ∆gmhAGC/Plac::gmhAGC

the ∆gmhAGC/Plac::gmhAGC mutant was 61.2 min (Figure 1d–e), a value

mutant grew scarcely after passage on solid media without IPTG,

similar to the parental wild-type strain (56.5 min; Figure 2b). In addi-

whereas abundant colonies were observed in the presence of the

tion, under nonpermissive conditions, we observed that the OD600 of

inducer (Figure 1a). The depletion of GmhAGC was corroborated by

the mutant culture continued to increase (Figure 1d) while the number

probing whole cell lysates of these gonococci with anti-GmhAGC an-

of viable bacteria remained at 107 CFUs/ml (Figure 1e). These results

tisera (Figure 1b). Visualization of LOS species by Tricine-SDS-PAGE

suggested that suppressors were arising in the mutant population but

coupled with silver staining showed, as expected, that bacteria de-

had not reached the point where they overcome the persistent popu-

prived of GmhAGC carried a truncated version of LOS that migrated

lation by the end of the 6-hr growth curve. We tested this possibility

faster in comparison with the LOS species isolated from wild-type and

by passaging ∆gmhAGC/Plac::gmhAGC on solid media without and with

∆gmhAGC/Plac::gmhAGC grown in the presence of IPTG (Figure 1b).

IPTG. After the third passage, ample bacterial colonies were obtained

Subsequently, time course experiments under standard laboratory
growth conditions were conducted to examine the correlation between
depletion of GmhAGC, LOS formation, and N. gonorrhoeae fitness. An
initial suspension of nonpiliated colonies of ∆gmhAGC/Plac::gmhAGC

with several mutations within the Plac, allowing expression of GmhAGC
and LOS synthesis (Fig. S2).
Together, these findings demonstrated that GmhAGC is pivotal for
LOS synthesis and optimal growth of N. gonorrhoeae.

collected from solid media supplemented with IPTG was divided and
cultured in liquid media in the presence or absence of IPTG [(+) or (−),
respectively]. After 3 hr, to ensure GmhAGC depletion, the corresponding cultures were diluted to OD600 of 0.1 in media with or without

3.3 | GmhAGC subcellular localization and
expression patterns

IPTG. From this point onward (shown as 0 hr in Figure 1c–e), samples

Preliminary results and absence of signal peptide suggested that

were withdrawn every hour to assess GmhAGC levels and LOS forma-

GmhA of E. coli is a cytoplasmic enzyme (Brooke & Valvano, 1996a).

tion (Figure 1c), culture density (Figure 1d), and colony forming units

However, subcellular localization of GmhA and expression patterns
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F I G U R E 2 Assessment of GmhAGC subcellular localization and expression patterns. (a) N. gonorrhoeae wild-type FA1090 cells were harvested
during mid-exponential phase and subjected to proteome extraction to separate cytoplasmic/periplasmic proteins (C), cell envelopes (CE),
naturally released membrane vesicles (MVs), and soluble proteins in culture supernatants (SS). Individual fractions were loaded based on the
total amount of protein (μg) and probed with antisera as indicated on the left. (b–c) Wild-type N. gonorrhoeae FA1090 was cultured in liquid
media and at indicated time points, OD600 measurements were taken (b) and samples were withdrawn and processed for immunoblotting
analysis of GmhAGC and Ng-MIP (c). (d) Quantities of GmhAGC and lipooligosaccharide (LOS) in wild-type FA1090 during in vitro conditions
relevant to different infection sites [standard growth under aerobic conditions (SGC), iron deprivation (-Iron), presence of normal human serum
(+NHS), and anaerobiosis (-O2)], were assessed by probing the whole cell lysates with anti-GmhAGC antibodies and silver staining of proteinase
K-extracted LOS, respectively. Immunoblotting experiments with antisera against Ng-MIP, TbpB, and AniA were used as markers for ubiquitous
expression, iron-limiting, and anaerobic conditions, respectively. (e) Effect of overexpression of GmhAGC on LOS amounts was examined by
harvesting wild-type FA1090 and isogenic ∆gmhAGC/Plac::gmhAGC grown on solid media with different isopropyl β-D-1-thiogalactopyranoside
(IPTG) concentrations (0, 20, or 1,000 μmol/L). Whole cell lysates were either probed with anti-GmhAGC antisera or treated with proteinase
K and LOS was visualized by silver staining. Experiments were performed in biological triplicates and representative immunoblots and silver-
stained gels are shown. Mean values and corresponding SEM are presented on the graph. Migration of a molecular mass marker (kDa) is
indicated on the left

F I G U R E 3 GmhAGC expression in a
panel of N. gonorrhoeae isolates. Whole
cell lysates of E. coli, wild-type FA1090,
∆gmhAGC/Plac::gmhAGC grown either
with (+) or without (−) isopropyl β-D-1-
thiogalactopyranoside (IPTG), and 36
additional strains of N. gonorrhoeae were
resolved on a 10–20% Tris-Glycine gel
and probed with anti-GmhAGC antibodies.
Immunoblotting with anti-Zwf antisera was
used as a loading control. Migration of a
molecular mass marker (kDa) is indicated
on the left

were never assessed. To examine the localization of GmhAGC,

envelopes, naturally released membrane vesicles, and soluble pro-

N. gonorrhoeae FA1090 was harvested at mid-logarithmic phase

teins in culture supernatants were separated by SDS-PAGE and

of growth and subjected to subfractionation procedures. Equal

probed with polyclonal antibodies (Figure 2a). GmhAGC was found

amounts of extracted proteome fractions including cytoplasm, cell

solely in the cytoplasmic protein fraction, similarly to the cytoplasmic
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enzyme glucose-6-phosphate 1-dehydrogenase, Zwf. As expected,

with all clinical isolates of N. gonorrhoeae, but no cross-reactivity was

the GTPase Obg (ObgGC), which primarily associates with 50S ribo-

detected for the E. coli GmhA homolog (Figure 3). In addition, there

somal subunits and partly with the peripheral inner membrane pro-

were noticeable differences in GmhAGC protein abundance between

teome (Papanastasiou et al., 2013; Zielke et al., 2015), was detected

the strains, while Zwf was uniformly expressed and there were no dis-

mainly in the cytoplasm and minute amounts were also found in the

crepancies in regard to samples normalization and loading (Figure 3

cell envelope fraction; whereas, antisera against the outer membrane

and Fig. S3).

protein marker BamA (Zielke et al., 2016) cross-reacted with fractions
containing cell envelopes and membrane vesicles.

E65A

(Figure 2b–c) and on solid media under conditions that more closely

wt

serum, and anoxia (Figure 2d). Antibodies against Ng-MIP, TbpB, and
AniA were used as markers for ubiquitous expression, iron-limiting

α-GmhAGC

conditions, and anaerobiosis, respectively (Cornelissen, 2008; Zielke
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20
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et al., 2014, 2016). Immunoblotting analyses of whole cell lysates
showed that expression of GmhAGC peaked during mid-exponential
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_

wild-type FA1090 during routine aerobic growth in liquid media

∆gmhAGC/Plac::gmhAGC

(a)

_

The expression of GmhAGC was subsequently examined in

LOS

phase (3 and 4 hr, Figure 2b–c). Increased GmhAGC levels were also
detected during iron deprivation and anaerobic growth in comparison with standard laboratory conditions (Figure 2d). As expected, expression of Ng-MIP remained constant throughout different phases
(b)

tion patterns in wild-type gonococci, albeit increased amounts of total
LOS were observed in bacteria cultured in the presence of normal
human serum and anaerobically (Figure 2d). To further assess the possible correlation between expression of GmhAGC and LOS levels, ∆gmhAGC/Plac::gmhAGC was cultured in increasing concentrations of IPTG.
The vast overexpression of GmhAGC achieved with 1,000 μmol/L IPTG
did not have adverse effect on bacterial growth (data not shown) and
had no effect on the LOS quantities (Figure 2e).
Cumulatively, these experiments demonstrated that GmhAGC
is a cytoplasmic enzyme with augmented expression during mid-
logarithmic phase, iron depletion and anaerobiosis, and that overproduction of GmhAGC alone does not alter gonococcal LOS abundance.

3.4 | Conservation of gmhA among Neisseria
Analysis of gmhA conservation showed that the gene (locus NGO1986,
NMB2090, NMC2070) is present in all of the 39,182 Neisseria spp.
genomes deposited into the PubMLST database (http://pubmlst.org/
neisseria/ as of July, 20, 2016) and that there are 340 alleles and 323
single nucleotide polymorphic sites (Fig. S4).
Expression of GmhAGC among 36 different N. gonorrhoeae strains
isolated from patients at different times and geographic locations,
including the 2016 WHO reference strains (Unemo et al., 2016),
was also assessed by immunoblotting. Whole cell lysates were resolved by SDS-PAGE and probed with either polyclonal anti-GmhAGC
antisera or Zwf antibodies, or stained with Coomassie brilliant blue
G-250 as a loading control. Antisera against GmhAGC cross-reacted
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tively (Figure 2d).
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upregulated during iron deprivation and anaerobic growth, respec-
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*
*

+

_

(Zielke et al., 2015, 2016), while TbpB and AniA were the most highly

+

E65A

_

of gonococcal growth and was unchanged under all tested conditions

+

H183A

∆gmhAGC/Plac::gmhAGC
F I G U R E 4 Hindering GmhAGC isomerase activity does not
influence N. gonorrhoeae growth. (a) Wild-type FA1090 and
isogenic conditional mutants carrying either native gmhAGC
(∆gmhAGC/Plac::gmhAGC) or mutated variants of GmhAGC
(∆gmhAGC/Plac::gmhAGCE65A or ∆gmhAGC/Plac::gmhAGCH183A) were
collected from solid media with (+) and without (−) isopropyl β-D-
1-thiogalactopyranoside (IPTG). Expression of individual GmhAGC
variants and lipooligosaccharide (LOS) patterns were examined
in whole cell extracts by immunoblotting and silver staining,
respectively. Samples were matched by equivalent OD600 units.
Migration of a molecular mass marker (kDa) is indicated on the left.
(b) Wild-type FA1090 and conditional mutants ∆gmhAGC/Plac::gmhAGC,
∆gmhAGC/Plac::gmhAGCE65A, and ∆gmhAGC/Plac::gmhAGCH183A were
collected from solid media supplemented with 20 μmol/L IPTG,
suspended in liquid media to OD600 of 0.1, cultured for 3 hr, back-
diluted to equal OD600 of 0.2, serially diluted, and spotted on solid
media in the presence (+) and absence (−) of IPTG. CFUs were scored.
The data show averages of CFUs with corresponding SEM of at least
three separate experiments; *p < .05
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3.5 | Hindering GmhAGC isomerase activity does not
influence N. gonorrhoeae growth
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LOS

D-glycero-α,β-D-manno-heptose-7-phosphate

(Taylor et al., 2008). Therefore, to determine whether the observed

kanamycin resistance cassette. Both mutated proteins were stably
produced in N. gonorrhoeae; however, the H183A variant was present at higher levels than the wild-type GmhAGC (Figure 4a). Silver

Bacterial growth
(Log10 CFU/ml)

wild-type FA1090, followed by allelic exchange of ngo1986 with the

8653-fold decline, respectively, in CFUs in comparison with wild-
type gonococci (Figure 4b). In contrast, the expression of either mutated version of GmhAGC rescued bacterial viability to the wild-type
level.
These in vivo studies demonstrated the importance of residues
E65 and H183 in GmhAGC activity in the production of full-length LOS
and suggested that abolition of LOS synthesis is disconnected from
the GmhAGC-dependent effect on N. gonorrhoeae viability.

3.6 | Transcomplementation studies of GmhA
GmhA homologs of H. influenzae and H. ducreyi restored the synthesis of full-length LPS in the E. coli ∆gmhA mutant (Bauer et al.,
1998; Brooke & Valvano, 1996a). This suggested that GmhA proteins can function interchangeably. However, failure of multiple
attempts to remove ngo1986 in FA1090 carrying the E. coli gmhA
gene cloned under the Plac promoter and integrated into the chromosome ruled out the possibility of a functional interspecies complementation. The E. coli GmhA (GmhAEC) shares 74% and 75%
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F I G U R E 5 Homologs of GmhA from N. gonorrhoeae and
N. meningitidis function interchangeably. (a) N. gonorrhoeae FA1090
wild-type and isogenic conditional gmhA mutants bearing either
endogenous (∆gmhAGC/Plac::gmhAGC) or N. meningitidis-derived
gmhANM (∆gmhAGC/Plac::gmhANM), as well as N. meningitidis MC58
wild-type and conditional gmhA mutants carrying gmhA alleles
(∆gmhANM/Plac::gmhANM or ∆gmhANM/Plac::gmhAGC) were harvested
from GCB after 22 hr of incubation either with (+) or without
(−) isopropyl β-D-1-thiogalactopyranoside (IPTG). Whole cell
lysates were probed with anti-GmhAGC antibodies or treated with
proteinase K and lipooligosaccharide (LOS) was visualized by silver
staining. Migration of a molecular mass marker (kDa) is indicated
on the left. (b) Wild-type and mutant strains of N. gonorrhoeae
and N. meningitidis, as described above, were collected from
GCB supplemented with 20 μmol/L IPTG and 15 μmol/L IPTG,
respectively. Bacteria were suspended in gonococcal base liquid
(GCBL) to OD600 of 0.1, cultured for 3 hr, back-diluted to equal OD600
of 0.2, serially diluted, and plated on GCB with (+) and without (−)
IPTG. CFUs were counted following 22 hr of incubation. Experiments
were performed in three independent replicates. Mean values and
SEM are presented; *p < .05

amino acid identity with H. influenzae and H. ducreyi proteins, re-

host, while without IPTG, neither GmhAGC nor GmhANM were de-

spectively, while only 50% identity exists between GmhAEC and

tected (Figure 5a). Functional interchangeability of GmhA between

GmhAGC (Table 3). In contrast, N. meningitidis GmhA (GmhANM)
shows 98% identity to GmhAGC, and anti-GmhAGC antisera readily recognized GmhANM (Figure 5a). Therefore, we decided to use

N. gonorrhoeae and N. meningitidis was then evaluated by analysis
of LOS patterns. In FA1090, ∆gmhAGC/Plac::gmhANM expression
of GmhANM resulted in LOS migrating exactly as LOS species ex-

an analogous strategy to create N. gonorrhoeae and N. meningitidis

tracted from the wild-type gonococci (Figure 5a). Likewise, expres-

∆gmhA strains expressing either endogenous or nonendogenous

sion of GmhAGC restored LOS synthesis in the N. meningitidis MC58

GmhA. Immunoblotting experiments demonstrated that under per-

∆gmhANM/Plac::gmhAGC. Furthermore, as expected from our studies

missive conditions, both proteins were stably expressed in each

in N. gonorrhoeae (Figure 1), depletion of GmhANM in N. meningitidis
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MC58 ∆gmhANM/Plac::gmhANM had adverse effects on bacterial vi-

TABLE 2

11 of 16

Data collection and refinement statistics

ability and resulted in a 300- and 235.7-fold decrease in CFUs in

N. gonorrhoeae GmhAGC
(PDB 5I01)

comparison with wild-type and ∆gmhANM/Plac::gmhANM cultured in
the presence of IPTG, respectively (Figure 5b). There was no sta-

Data collection

tistically significant difference in the number of CFUs between
the wild-type N. gonorrhoeae and its isogenic ∆gmhAGC mutant
expressing either GmhAGC or GmhANM (Figure 5b). Similarly, both

Wavelength (Å)

1.0000

Space group

P21212

Cell dimensions:

GmhANM and GmhAGC fully complemented the lack of GmhANM in

a, b, c (Å)

N. meningitidis.

α, β, γ (°)

Together, the transcomplementation studies showed that the

114.36, 130.15, 47.15
90, 90, 90

N. gonorrhoeae and N. meningitidis GmhA can function interchange-

Resolution (Å)

85.91–2.37 (2.43–2.37)a

ably. Expression of either of the homologs restored both viability and

Rsym

0.134 (1.032)

LOS synthesis. Additionally, we concluded that E. coli GmhAEC is not

b

able to complement GmhAGC functions, as we were not able to generate a viable N. gonorrhoeae ∆gmhAGC/Plac::gmhAEC mutant.

3.7 | The structure of N. gonorrhoeae GmhA

CC1/2

99.6 (62.4)

I/σI

9.3 (1.7)

Completeness (%)

95.8 (97.8)

Multiplicity

3.7 (3.6)

Refinement

To gain insights into the function of GmhAGC and to facilitate the
future targeting of this enzyme with small molecule inhibitors, we
obtained recombinant protein for structural studies (Fig. S1). The

Resolution (Å)

85.91–2.37

No. reflections (total/free)

28191/1405

Rwork/Rfree

0.207/0.267

Number of atoms:

structure of N. gonorrhoeae GmhA was determined by molecular re-

Protein

5411

0.267, and excellent stereochemical parameters (Table 2). Four mono-

Ligand/ion

4

mers of GmhAGC were present in the asymmetric unit (Figure 6a). The

Water

101

tetrameric architecture is consistent with the results of size exclusion

B-factors:

chromatography (Fig. S1A), and with the previously determined struc-

Protein

37.6

tures of GmhA homologs from other bacteria (Table 3). The interface

Ligand/ion

54.9

Water

32.7

All atoms

37.2

Wilson B

41.2

placement and was refined to 2.37 Å resolution with Rwork 0.207, Rfree

area of the GmhAGC tetramer is extensive and buries 14,160 Å2 of surface area as calculated by the PISA server (Krissinel & Henrick, 2007).
Four subunits of GmhAGC adopt highly similar structures with root
mean square deviation (r.m.s.d.) 0.1–0.2 Å between subunits. Residues

R.m.s. deviations:

69–74 (chains A and B) and 69–75 (chains C and D) are disordered in
the structure. These residues form a loop in the vicinity of the active
site and could become ordered upon substrate binding. A similar diset al., 2008).
Each monomer of GmhAGC is composed of a central five-stranded
parallel β-sheet flanked by four α-helices from each side (Figure 6b).
coordinated by the side chains of residues H61, E65, and H183 of
one monomer, and the side chain of Q175 of the neighboring monomer (Figure 6c). Therefore, the zinc-binding sites of GmhAGC are
identical to the zinc-binding sites of B. pseudomallei GmhA (Harmer,
2010).
Overall, the structure of GmhAGC is similar to the previously de-

0.009

Bond angles (°)

1.224

Ramachandran distributionc (%):

order was observed in the homologous region of E. coli GmhA (Taylor

Four zinc ions are present in the GmhAGC tetramer. The zinc ions are

Bond lengths (Å)

Favored

97.8

Outliers

0

a

Values in parentheses are for the highest resolution shell.
CC1/2 correlation coefficient as defined in (Karplus & Diederichs, 2012)
and calculated by XSCALE (Kabsch, 2010b).
c
Calculated using the MolProbity server (http://molprobity.biochem.duke.
edu) (Chen et al., 2010).
b

4 | DISCUSSION

termined structures of GmhA from other bacteria, as well as E. coli

GmhA is a conserved sedoheptulose-7-phosphate isomerase involved

DiaA (Table 3). The monomer structure of GmhAGC could be super-

in the first biosynthesis step of the L,D-heptose component of the

imposed to the homologous structures with r.m.s.d. of 0.5–1.4 Å. The

LPS/LOS. Deprivation of heptoses results in pleiotropic phenotypes

tetramer structure of GmhAGC forms a “closed” conformation, similar

including synthesis of LPS/LOS molecules composed only of lipid A

to the GmhA structures of P. aeruginosa, V. cholerae, B. pseudomallei,

and KDO residues, increased susceptibility to antimicrobial agents,

and C. psychrerythraea (Do et al., 2015; Harmer, 2010; Seetharaman

defects in plasmid F conjugations and P1 bacteriophage transduction,

et al., 2006; Taylor et al., 2008).

and decreased virulence and biofilm formation (Bauer et al., 1998;

12 of 16
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F I G U R E 6 The structure of
N. gonorrhoeae GmhAGC. (a) The ribbon
representation of GmhAGC tetramer with
monomers colored in green, yellow, cyan,
and magenta. Zn2+ ions are shown as gray
spheres. (b) The structure of GmhAGC
monomer is colored in rainbow colors
from blue (N-terminus) to red (C-terminus).
The α-helices are labeled according to
Seetharaman et al., 2006. (c) A close-up
view of the Zn2+-binding site of GmhAGC.
The coordinating side chains are shown
in stick representation. The σA-weighted
2FO–FC electron density map countered at
1.0 σ is displayed as blue mesh
Brooke & Valvano, 1996a; Earl et al., 2015; Havekes et al., 1976;

essential genes identified using a high-density Tn5 transposon library

Malott et al., 2013; Tamaki et al., 1971). In N. gonorrhoeae, heptoses

(Remmele et al., 2014). In addition, expression of GmhAGC variants

are also crucial for LOS function in the evasion of the host immune

carrying substitutions in the catalytic residues coordinating zinc ions,

system and induction of HIV expression (Malott et al., 2013; Preston

E65, and H183 (Figure 6c), led to synthesis of truncated LOS while

et al., 1996). Variability in LOS molecules on the gonococcal surface

retaining ample N. gonorrhoeae viability (Figure 4). These findings

is driven by phase variable enzymes responsible for decorating the

suggested that GmhAGC may be involved in additional physiological

sugar moiety of the outer core oligosaccharide (Apicella et al., 1987;

function(s) in Neisseria. Not surprisingly, a complete functional trans-

Danaher et al., 1995). N. gonorrhoeae scavenges sialic acid from the

complementation was achieved between GhmAGC and GmhANM

human body and modifies the lacto-N-neotetraose attached to the

(Figure 5a–b), whereas multiple attempts to generate a viable strain of

HepI of the LOS core oligosaccharide, which provides protection from

N. gonorrhoeae expressing only GmhAEC were unsuccessful (data not

killing by classical and alternative complement pathways (Elkins et al.,

shown). Based on these findings, we concluded that GmhA plays a crit-

1992; Ram et al., 1998). Thus, inhibition of GmhA could aid in treat-

ical role in LOS synthesis and is a fundamental growth factor for both

ment of infections caused by different pathogenic bacteria including

N. gonorrhoeae and N. meningitidis.

N. gonorrhoeae.
Accordingly, in this work, we presented initial characterization

Profiling of GmhAGC expression showed that amounts of GmhAGC
increased during exponential growth of wild-type N. gonorrhoeae

of GmhAGC at the functional and structural levels. Our experiments

(Figure 2c). Surprisingly, the isogenic conditional ∆gmhAGC/Plac::gm-

demonstrated that gonococci and meningococci depleted in GmhA

hAGC mutant cultured in the presence of IPTG had elevated levels of

produced overall significantly less LOS molecules that migrated

GmhAGC during the late logarithmic phase (Figure 1c–e), suggesting

faster in comparison with the LOS-derived from wild-type bacteria

that expression of GmhAGC is regulated at the posttranscriptional (e.g.,

(Figures 1b and 5a). In contrast to other orthologs, however, diminu-

small noncoding RNAs, RNA-binding proteins, RNases, and thermos-

tion of the GmhA cellular pool had severe consequences on neisserial

switches) or posttranslational levels. Higher amounts of GmhAGC were

growth (Figures 1a, d–e and 5b). This protein is likely not essential for

also noted upon exposure of N. gonorrhoeae to environmental cues

bacterial viability, as GmhA-depleted neisserial cells still arose on solid

relevant to infection; iron deprivation and anaerobiosis (Figure 2d).

media under nonpermissive conditions (Figure 1a, d–e). Corroborating

Transcriptomic studies, however, did not identify GmhAGC as an iron-

this observation, gmhAGC was not found among 827 gonococcal core

regulated gene (Ducey, Carson, Orvis, Stintzi, & Dyer, 2005; Jackson
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TABLE 3
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Structural homologs of N. gonorrhoeae GmhAGC

Protein

Organism

r.m.s.d.a

Sequence identitya (%)

Ligands

PDB ID

Reference

GmhA

P. aeruginosa

0.5

57

D-glycero-α-D-manno-
heptopyranose-7-phosphate

1X92

(Taylor et al., 2008)

DiaA

E. coli

0.7

52

apo

2YVA

(Keyamura et al., 2007)

DiaA

E. coli

0.7

52

apo

4U6N

unpublished

GmhA

F. tularensis

0.7

45

apo

3TRJ

(Chaudhury et al., 2013)

GmhA

C. psychrerythraea

0.7

48

apo

5BY2

(Do et al., 2015)

GmhA

C. jejuni

0.7

54

apo

1TK9

(Seetharaman et al., 2006)

GmhA

P. aeruginosa

0.8

56

apo

3BJZ

(Taylor et al., 2008)

GmhA

B. pseudomallei

0.8

43

Zn2+

2X3Y

(Harmer, 2010)

GmhA

B. pseudomallei

0.9

43

Zn2+, D-glycero-α-D-
manno-heptopyranose-
7-phosphate

2XBL

(Harmer, 2010)

GmhA

E. coli

1.4

45

apo

2I2W

(Taylor et al., 2008)

GmhA

E. coli

1.1

45

D-sedoheptulose-7-phosphate

2I22

GmhA

V. cholerae

1.1

43

apo

1X94

(Seetharaman et al., 2006)

a
As reported by the Dali server (Holm & Rosenstrom, 2010) for superposition of monomers. A mean value is listed for the structures containing more than
one protein subunit in the asymmetric unit.

et al., 2010). The observed upregulation of GhmAGC under anaerobic

the structures of homologs from other bacteria did not reveal signifi-

conditions was in agreement with deep sequencing analysis of the

cant differences in the general organization of the structure or within

N. gonorrhoeae anaerobic stimulon, where gmhAGC was found to be

the catalytic site of the enzyme. Zinc ions were not added to any of

4.2-and 6.1-fold upregulated in two biological experiments (Isabella &

the protein purification steps or crystallization buffers, yet similar to

Clark, 2011). Higher levels of enzymes acting downstream from GmhA

Burkholderia pseudomallei GmhA (Harmer, 2010), GmhAGC held zinc

including HldA (NGO0402) and GmhB (NGO2070) were identified in

ions in the active site (Figure 6c), providing further support that GmhA

anaerobically versus aerobically cultured gonococci in our recent high-

is a metalloenzyme. Zinc is likely retained from the cell of the heter-

throughput proteomic studies (Zielke et al., 2016), suggesting that

ologous host during protein overproduction and natively bound to

the L,D-heptose biosynthesis pathway is upregulated during anoxia.

the active site of the enzyme. Zinc binding likely drives the “closed”

Accordingly, increased amounts of LOS were detected in anaerobically

conformation of GmhAGC, which was also observed in structures of

grown gonococci (Figure 2d), while vast overexpression of GhmAGC

B. pseudomallei, P. aeruginosa, and V. cholerae GmhA (Table 3), thus pro-

alone had no effect on LOS levels (Figure 2e). GmhAGC expression

viding further support that the “closed” conformation is catalytically

was also studied in a diverse collection of gonococcal isolates, includ-

relevant. In addition, site-directed mutagenesis coupled with in vivo

ing the 2016 WHO reference strains (Unemo et al., 2016) containing

studies confirmed the pivotal function of GmhAGC E65 and H183 in

multidrug-resistant N. gonorrhoeae (Figure 3). Potential involvement

the isomerization of the sedoheptulose-7-phosphate (Figures 4 and 6).

of GmhA in antibiotic resistance via increased synthesis of LPS was

In conclusion, understanding the function and structure of individ-

suggested recently in Salmonella typhimurium DT104B multiresis-

ual GmhA proteins will facilitate drug discovery approaches focused

tant strain with additional fluoroquinolone resistance (Correia et al.,

on targeting this protein with small molecule inhibitors. In particular,

2016). Notwithstanding this suggestion, the amounts of GmhAGC var-

our work demonstrated the crucial function of GmhA in neisserial

ied widely between the WHO strains K, L, V, W, X, Y, and Z, which

growth and LOS synthesis, positive regulation of expression by host-

display overall high levels of ciprofloxacin resistance (MIC>32 mg/L)

relevant environmental stimuli, and conservation among different iso-

and decreased susceptibility to gemifloxacin and moxifloxacin (Unemo

lates, as well as provided further support for the mode of action of

et al., 2016). Additionally, strain L, which has high MICs for all quino-

GmhA. These findings underscore the significance of GmhAGC as a tar-

lones (MICs in mg/L for ciprofloxacin, gemifloxacin, and moxifloxacin

get for antigonorrhea therapeutics. Future work involving determining

of >32, 8, and 16, respectively), showed significantly lower GmhAGC

the interacting partner(s) of GmhAGC and analysis of global changes

levels in comparison with WHO isolates F, O, P, and U, which are all

at the proteome and metabolome levels are required to elucidate the

ciprofloxacin sensitive (MIC of 0.004 mg/L) and are significantly more

whole scope of physiological function(s) of GmhAGC in N. gonorrhoeae.

sensitive to gemifloxacin and moxifloxacin (MICs ranging from 0.004
to 0.016 mg/L).
Finally, to better understand the pivotal function of GmhAGC, we
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